The metabolic function of FGF21 was first described in 2005 in a seminal publication that outlined its capacity to increase glucose uptake in adipocytes, and its ability to protect against obesity, hyperglycaemia, and hypertriglyceridemia in mice [42]. This evidence concerns the gene FGF21 and hypertriglyceridemia.